March 10, 2026 a 07:43 am
TECH: Fundamental Ratio Analysis - Bio-Techne Corporation
The Bio-Techne Corporation has established itself as a leading biotechnology firm with a broad product portfolio spanning life science reagents, diagnostics, and genomics. Its strong presence in the healthcare sector positions it well for growth. However, investors should consider both the opportunities and inherent risks associated with its market segment.
Fundamental Rating
Bio-Techne's fundamental rating suggests a balanced financial position with some room for improvement. Here is a breakdown of the scores across different categories:
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return on Equity | 3 | |
| Return on Assets | 4 | |
| Debt to Equity | 3 | |
| Price to Earnings | 1 | |
| Price to Book | 2 |
Historical Rating
The historical rating provides insight into how Bio-Techne's scores have evolved. As of the latest evaluation, scores remain consistent with past assessments:
| Date | Overall Score | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-03-09 | 3 | 3 | 3 | 4 | 3 | 1 | 2 |
| N/A | 0 | 3 | 3 | 4 | 3 | 1 | 2 |
Analyst Price Targets
Price targets set by analysts present a median consensus close to the actual stock price, suggesting a stable outlook:
| High | Low | Median | Consensus |
|---|---|---|---|
| $79 | $62 | $69 | $69.33 |
Analyst Sentiment
The current analyst sentiment reflects a general positive outlook, predominantly with "Buy" recommendations:
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 18 | |
| Hold | 7 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Bio-Techne Corporation demonstrates solid financial health with stable historical scores and a supportive analyst sentiment. The biotechnology sector offers growth opportunities, but investors should be mindful of potential volatility. With a balanced score distribution and optimistic price targets, the stock remains appealing for those seeking stability. However, its relatively low P/E ratio warrants closer inspection. Overall, Bio-Techne presents potential long-term value amidst the dynamic biotechnology landscape.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years